Lerisetron

DB12964InvestigationalSmall molecule

Lerisetron has been used in trials studying the supportive care of Nausea and Vomiting and Testicular Germ Cell Tumor.

Chemical structure of Lerisetron
Mechanism
Curator reviewed
Formula / weight
C18H20N4 · 292.386 g/mol (avg)

Resolves to

Compound
UNIIQ36R82SXRGCAS143257-98-1ChEMBLCHEMBL56900PubChem65997
Structure
InChIKeyPWWDCRQZITYKDV-UHFFFAOYSA-NSMILESC(N1C2=CC=CC=C2N=C1N1CCNCC1)C1=CC=CC=C1

What you can answer from here — as of July 07, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
10+ReferencesStructured and connected to the statements they support
Sign in

Which companies are running trials of Lerisetron, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In